TMEM106B and early-onset autosomal dominant Alzheimer disease: Elevated levels of TMEM106B in mild cognitive impairment, Alzheimer’s disease and during hippocampal reinnervation in rodents all point to an active response to tissue damage that is consistent with compensatory synaptic and terminal remodeling.